Endoscopic ultrasound for structured surveillance after curative treatment of esophageal cancer
Zeitschrift für Gastroenterologie · 01.05.2024 · 62 (05) · 737-746
DOI: 10.1055/a-2125-6923 ↗Kurz gefasst
Fachartikel in der Zeitschrift Zeitschrift für Gastroenterologie, erschienen am 01.05.2024. Verfasst von Wolfram Bohle und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, Katharinenhospital, Klinikum Stuttgart, Stuttgart, Germany. Hauptthemen laut MEDLINE: Esophageal Neoplasms, Endosonography, Neoplasm Recurrence, Local. Die Arbeit nennt 31 Literaturangaben.
Abstract (Originalsprache)
Background
Structured surveillance after treatment of esophageal cancer is not established. Due to a paucity of data, no agreement exists on how surveillance should be performed. The main argument against intensive follow-up in esophageal cancer is that it may not lead to true survival advantage.
Methods
Structured surveillance was performed in 42 patients after multimodal therapy with peri-operative chemotherapy (29) or definitive chemoradiotherapy (13) of esophageal cancer. The surveillance protocol included gastroscopy, endoscopic ultrasound, chest X-ray, abdominal ultrasound, and CEA measurement at regular intervals of up to five years. We analyzed relapse rate, time to relapse, localization of recurrence, diagnosis within or without structured surveillance, diagnostic method providing the first evidence of a relapse, treatment of recurrence, and outcome.
Results
Median follow-up was 48 months; 18/42 patients suffered from tumor relapse, with 16 asymptomatic patients diagnosed within structured surveillance. Median time to recurrence was 9 months. Isolated local or locoregional recurrence occurred in 6, and isolated distant relapse in 9 patients. All patients with isolated locoregional recurrence were exclusively diagnosed with endoscopic ultrasound. Six patients received curatively intended therapy with surgery or chemoradiation, leading to long-lasting survival.
Conclusion
Structured surveillance offers the chance to identify limited and asymptomatic tumor relapse. Especially in cases of locoregional recurrence, long-lasting survival or even a cure can be achieved. Endoscopic ultrasound is the best method for the detection of locoregional tumor recurrence and should be an integral part of structured surveillance after curative treatment of esophageal cancer.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Autor:innen und Institutionen
- Department of Gastroenterology, Katharinenhospital, Klinikum Stuttgart, Stuttgart, Germany.
- Deparment of Gastroenterology, Katharinenhospital, Klinikum Stuttgart, Stuttgart, Germany.
- Department of Surgery, Katharinenhospital, Klinikum Stuttgart, Stuttgart, Germany.
- Department of Surgery, Klinikum Stuttgart Katharinenhospital, Stuttgart, Germany.
- Department of Gastroenterology, Klinikum Stuttgart Katharinenhospital, Stuttgart, Germany.
Zitieren
APA
Bohle, W., Nowack, L., Schaudt, A., Koeninger, J., Zoller, W. G., & Albert, J. G. (2024). Endoscopic ultrasound for structured surveillance after curative treatment of esophageal cancer. Zeitschrift für Gastroenterologie, 62(05), 737-746. https://doi.org/10.1055/a-2125-6923
Vancouver
Bohle W, Nowack L, Schaudt A, Koeninger J, Zoller WG, Albert JG. Endoscopic ultrasound for structured surveillance after curative treatment of esophageal cancer. Zeitschrift für Gastroenterologie. 2024;62(05):737-746. doi:10.1055/a-2125-6923
BibTeX
@article{Bohle2024,
author = {Bohle, Wolfram and Nowack, Lioba and Schaudt, Andre and Koeninger, Joerg and Zoller, Wolfram G and Albert, Jörg G},
title = {Endoscopic ultrasound for structured surveillance after curative treatment of esophageal cancer},
journal = {Zeitschrift für Gastroenterologie},
year = {2024},
volume = {62},
number = {05},
pages = {737--746},
doi = {10.1055/a-2125-6923}
}
EUVIMED